On the public citation graph

Optimization for the Production of a Dengue Live-Attenuated Quadrivalent Vaccine in Vero Cells Grown on Microcarriers

https://doi.org/10.2139/ssrn.4951803
0 signed · 24 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/elsc.201400165openalex-extracted
Oncolytic measles viruses produced at different scales under serum‐free conditions
inferredcites →https://doi.org/10.1007/s00253-009-2064-yopenalex-extracted
A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor
inferredcites →https://doi.org/10.1007/s00253-010-2742-9openalex-extracted
MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation
inferredcites →https://doi.org/10.1007/s10616-020-00377-9openalex-extracted
Rapid process development of serum-free pseudorabies virus production with the Quality by Design approach
inferredcites →https://doi.org/10.1016/j.biotechadv.2010.11.008openalex-extracted
Review of dengue virus and the development of a vaccine
inferredcites →https://doi.org/10.1016/j.biotechadv.2020.107608openalex-extracted
Vero cell upstream bioprocess development for the production of viral vectors and vaccines
inferredcites →https://doi.org/10.1016/j.jbiotec.2020.01.015openalex-extracted
Serum-free production of rVSV-ZEBOV in Vero cells: Microcarrier bioreactor versus scale-X™ hydro fixed-bed
inferredcites →https://doi.org/10.1016/j.vaccine.2011.07.020openalex-extracted
Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
inferredcites →https://doi.org/10.1016/j.vaccine.2014.02.028openalex-extracted
Implementation of QbD for the development of a vaccine candidate
inferredcites →https://doi.org/10.1016/j.vaccine.2017.02.042openalex-extracted
Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture
inferredcites →https://doi.org/10.1016/j.vaccine.2019.06.029openalex-extracted
Defining the multiplicity and time of infection for the production of Zaire Ebola virus-like particles in the insect cell-baculovirus expression system
inferredcites →https://doi.org/10.1016/j.xphs.2019.02.004openalex-extracted
Quality by Design-Driven Process Development of Cell Culture in Bioreactor for the Production of Foot-And-Mouth Veterinary Vaccine
inferredcites →https://doi.org/10.1016/j.xphs.2019.09.008openalex-extracted
Quality by Design-Driven Process Development of Severe Fever With Thrombocytopenia Syndrome Vaccine
inferredcites →https://doi.org/10.1016/s0264-410x(97)00301-0openalex-extracted
Development of a mammalian cell (Vero) derived candidate influenza virus vaccine
inferredcites →https://doi.org/10.1016/s1473-3099(17)30166-4openalex-extracted
Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study
inferredcites →https://doi.org/10.1080/21645515.2018.1445448openalex-extracted
Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine
inferredcites →https://doi.org/10.1080/21645515.2019.1658503openalex-extracted
A review of Dengvaxia®: development to deployment
inferredcites →https://doi.org/10.1093/cid/ciab864openalex-extracted
Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)
inferredcites →https://doi.org/10.1093/infdis/jiaa761openalex-extracted
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination
inferredcites →https://doi.org/10.1093/infdis/jiv082openalex-extracted
Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
inferredcites →https://doi.org/10.1186/1472-6750-11-81openalex-extracted
Serum-free microcarrier based production of replication deficient Influenza vaccine candidate virus lacking NS1 using Vero cells
inferredcites →https://doi.org/10.1186/s12985-021-01566-4openalex-extracted
The basic reproductive number and particle-to-plaque ratio: comparison of these two parameters of viral infectivity
inferredcites →https://doi.org/10.1371/journal.pntd.0004821openalex-extracted
Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1038/s41598-025-33792-zopenalex-snapshot
Suspension cultivation of mosquito cell lines for the production of the mosquito-borne flavivirus Usutu virus in a stirred-tank bioreactor
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.